Generics makers expected to ramp up Viagra copies; Elder gets OK for API;

> Drug company Elder Pharmaceuticals has received certificate of suitability from European regulators for Diosmin API, a drug used to treat vascular diseases. Item

> The World Health Organization has expressed interest in seeing SMS text technology used to fight counterfeits in some countries. Item

> Indian generics maker Cipla is slashing by 63% the price on another cancer drug, this time targeting Roche's ($RHHBY) lung cancer drug Tarceva. Story

> India-based Sun Pharmaceutical is buying U.S. dermatology drugmaker DUSA Pharmaceuticals for about $230 million. Story

> Agere Pharmaceuticals says it upgraded its manufacturing capabilities so it can now provide spray drying. Item

And Finally... Pfizer ($PFE) expects generics makers to start churning out copycat versions of Viagra after a court in Canada sided with Teva Pharmaceutical Industries ($TEVA) and invalidated Pfizer's patent there. Story